The 4th isirv-AVG conference on Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench To Bedside was held in Austin, Texas 2-4 June 2015

A brief report is available here

A workshop, organised by ISIRV-AVG, GISAID and PREDEMICS, on Next Generation Sequencing Of Viruses was held in Paris, France 20-21 May 2015

A brief report is available here

The 3rd isirv-AVG conference on Influenza and Other Respiratory Virus Infections: Advances in Clinical Management was held in Tokyo on 4-6 June 2014.

The Programme and Abstract book is available here, a brief summary is available here and a published overview is available here 

An AVG discussion meeting on Clinical Trial Endpoints for Studies of Antivirals in Hospitalised and At-Risk Patients was held on 8 September 2013 in Cape Town during the Options for the Control of Influenza VIII conference.

The agenda is available here             A Summary report is available here

A short training workshop on Sequence Analysis and Detection of Antiviral Resistance was co-organised with GISAID, with support from WHO, on 7 September 2013 in Cape Town during the Options for Control of Influenza VIII conference. A report is available here

The 2nd isirv-AVG conference on Severe Influenza: Burden, Pathogenesis and Management held in Hanoi on 29-31 October 2012, was co-organised with The National Institute of Hygiene and Epidemiology, with a focus on South East Asia.  

The conference programme, abstract book and meeting summary are available here

Proceedings, published as a special issue of Influenza and Other Respiratory Viruses, are available here

The inaugural meeting on Influenza Antivirals: Efficacy and Resistance in Rio de Janeiro on 8-10 November 2011 was co-organised with the Oswaldo Cruz Foundation with a focus on Latin America.

A summary of the meeting is available here    

 Proceedings, published as a special issue of Influenza and Other Respiratory Viruses, are available here

The isirv-AVG predecessor organisation, NISN (the Neuraminidase Inhibitor Susceptibility Network), published an overview of antiviral drug resistance data presented at Options for the Control of Influenza VII, Hong Kong in September 2010.

The meeting report can be found here